Proactive Diagnostics
Proactive Diagnostics offers affordable, at-home inflammation monitoring via a point-of-care testing platform, using machine learning for personalized health insights.
Founded
2017Proactive Diagnostics offers affordable, at-home inflammation monitoring via a point-of-care testing platform, using machine learning for personalized health insights.
Proactive Diagnostics, founded to revolutionize at-home health monitoring, focuses on providing affordable, point-of-care testing for chronic inflammation. Their core mission is to empower patients and physicians with accurate, real-time health data through a novel testing platform enabled by Q-SENS technology and powered by AI. The service integrates machine learning to offer personalized health insights, combining test results with personal data such as diet and stress levels, all accessible via mobile devices.
Notable achievements include securing a BARDA contract for the development of their Q-SENS technology, underscoring their innovation and potential impact in the healthcare sector. Proactive Diagnostics' platform has significantly enhanced patient autonomy and proactive health management, allowing for timely interventions and improved chronic disease outcomes. Their work is supported by key investors and industry experts dedicated to advancing personalized medicine and home-based healthcare solutions.
Companies similar to Proactive Diagnostics include Clinicai, Probius, Proxim Diagnostics and Predictive Health Diagnostics Company.
Proactive Diagnostics was founded in 2017.
Proactive Diagnostics' headquarters is located in Thousand Oaks, CA, US.
Proactive Diagnostics' most recent funding round was for $2M (USD) in November 2022.
As of Nov 2, 2022, Proactive Diagnostics has disclosed funding of $2M (USD). Undisclosed round amounts are excluded.
Proactive Diagnostics has 3 employees as of Feb 5, 2024.
Predictive Health Diagnostics Company
